Lilly’s Bio-Medicines Portfolio Grows To Offset Pressures In Key Markets

Where Rebates Eat Into Prices, Volume Makes Up The Difference

 
• By Mandy Jackson
Pressure meter or indicator
With pressure growing in areas like psoriasis, Lilly Bio-Medicines is expanding into other inflammatory diseases like ulcerative colitis • Source: Shutterstock

More from Strategy

More from Business